St Vincent's Hospital is a major hospital in Fitzroy, Melbourne, Australia. It is operated by the St Vincent's Health service, previously known as the Sisters of Charity Health Service, Melbourne. It is situated at the corner of Nicholson Street and Victoria Street.

There are 504 beds in St Vincents Hospital Melbourne.

During the past decade, St Vincents Hospital Melbourne conducted 201 clinical trials. In the 10-year time frame, 201 clinical trials started and 97 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 46 clinical trials were completed. i.e. 60.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Vincents Hospital Melbourne" #1 sponsor was "Celgene" with 16 trials, followed by "Gilead Sciences" with 15 trials sponsored, "St Vincent's Hospital Melbourne" with 13 trials sponsored, "BeiGene" with 12 trials sponsored and "Hoffmann-La Roche" with 12 trials sponsored. Other sponsors include 273 different institutions and companies that sponsored additional 160 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Vincents Hospital Melbourne" #1 collaborator was "National Health and Medical Research Council, Australia" with 11 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Australasian Gastro Intestinal Research Foundation" with 3 trials as a collaborator. Other collaborators include 198 different institutions and companies that were collaborators in the rest 166 trials.

According to Clinical.Site data, the most researched conditions in "St Vincents Hospital Melbourne" are "Coronary Artery Disease" (21 trials), "Multiple Myeloma" (14 trials), "Ulcerative Colitis" (13 trials), "Crohn Disease" (11 trials) and "Crohn's Disease" (10 trials). Many other conditions were trialed in "St Vincents Hospital Melbourne" in a lesser frequency.

Most popular intervention types in "St Vincents Hospital Melbourne" are "Drug" (257 trials), "Device" (45 trials), "Other" (34 trials), "Biological" (26 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (74 trials), "Dexamethasone" (10 trials), "Lenalidomide" (9 trials), "Rituximab" (8 trials) and "Bortezomib" (7 trials). Other intervention names were less common.

The vast majority of trials in "St Vincents Hospital Melbourne" are 333 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 129 active trials in "St Vincents Hospital Melbourne". 1 are not yet recruiting, 76 are recruiting, 46 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 159 completed trials in St Vincents Hospital Melbourne, 1 suspended trials, and 39 terminated clinical trials to date.

Out of the total trials that were conducted in St Vincents Hospital Melbourne, 34 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 166 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 45 trials that are defined as “Not Applicable".

St Vincents Hospital Melbourne has several departments that took part in Clinical trials: "St Vincent'S Hospital; Haematology" - 2 trials